FI930694A - Menetelmä terapeuttisesti käyttökelpoisten nonapeptidi- ja dekapeptidianalogien valmistamiseksi, jotka ovat LHRH:n antagonisteja - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten nonapeptidi- ja dekapeptidianalogien valmistamiseksi, jotka ovat LHRH:n antagonisteja Download PDF

Info

Publication number
FI930694A
FI930694A FI930694A FI930694A FI930694A FI 930694 A FI930694 A FI 930694A FI 930694 A FI930694 A FI 930694A FI 930694 A FI930694 A FI 930694A FI 930694 A FI930694 A FI 930694A
Authority
FI
Finland
Prior art keywords
nonapeptide
alanyl
preparation
image
lhrh
Prior art date
Application number
FI930694A
Other languages
English (en)
Swedish (sv)
Other versions
FI92211B (fi
FI930694A0 (fi
FI92211C (fi
Inventor
Jr John J Nestor
Brian H Vickery
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI930694A0 publication Critical patent/FI930694A0/fi
Publication of FI930694A publication Critical patent/FI930694A/fi
Publication of FI92211B publication Critical patent/FI92211B/fi
Application granted granted Critical
Publication of FI92211C publication Critical patent/FI92211C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
FI930694A 1987-02-05 1993-02-17 Menetelmä terapeuttisesti käyttökelpoisten nonapeptidi- ja dekapeptidianalogien valmistamiseksi, jotka ovat LHRH:n antagonisteja FI92211C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1092387 1987-02-05
US07/010,923 US4801577A (en) 1987-02-05 1987-02-05 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
FI880509A FI92326C (fi) 1987-02-05 1988-02-04 LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
FI880509 1988-02-04

Publications (4)

Publication Number Publication Date
FI930694A0 FI930694A0 (fi) 1993-02-17
FI930694A true FI930694A (fi) 1993-02-17
FI92211B FI92211B (fi) 1994-06-30
FI92211C FI92211C (fi) 1994-10-10

Family

ID=21748050

Family Applications (2)

Application Number Title Priority Date Filing Date
FI880509A FI92326C (fi) 1987-02-05 1988-02-04 LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
FI930694A FI92211C (fi) 1987-02-05 1993-02-17 Menetelmä terapeuttisesti käyttökelpoisten nonapeptidi- ja dekapeptidianalogien valmistamiseksi, jotka ovat LHRH:n antagonisteja

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI880509A FI92326C (fi) 1987-02-05 1988-02-04 LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina

Country Status (22)

Country Link
US (2) US4801577A (fi)
EP (1) EP0277829B1 (fi)
JP (1) JPH0791314B2 (fi)
KR (1) KR930008095B1 (fi)
AT (1) ATE109159T1 (fi)
AU (1) AU614275B2 (fi)
BR (1) BR1100688A (fi)
CA (1) CA1339043C (fi)
DE (2) DE3850789T2 (fi)
DK (1) DK173544B1 (fi)
ES (1) ES2056908T3 (fi)
FI (2) FI92326C (fi)
HK (1) HK35997A (fi)
HU (3) HUT63855A (fi)
IE (1) IE63707B1 (fi)
IL (1) IL85316A (fi)
LU (1) LU90657I2 (fi)
MX (1) MX9202737A (fi)
NL (1) NL300016I2 (fi)
NO (3) NO176440C (fi)
NZ (1) NZ223403A (fi)
ZA (1) ZA88795B (fi)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
EP0312052B1 (en) * 1987-10-15 1994-01-05 Syntex (U.S.A.) Inc. Intranasal administration of polypeptides in powdered form
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
US5039660A (en) * 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
WO1990010437A1 (en) * 1989-03-09 1990-09-20 Endocon, Inc. Partially fused peptide pellet
US6156731A (en) * 1989-05-10 2000-12-05 G. D. Searle & Co. Polypeptide composition for oral administration
US5232707A (en) * 1989-07-10 1993-08-03 Syntex (U.S.A.) Inc. Solvent extraction process
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
US5212288A (en) * 1990-02-20 1993-05-18 Syntex (U.S.A.) Inc. Temporary minimal protection synthesis of serine-containing polypeptides
EP0477499B1 (de) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Gonadoliberin-Antagonisten
US5783562A (en) * 1990-11-10 1998-07-21 Asta Medica Aktiengesellschaft Luteinizing hormone releasing hormone analogs
CN1036343C (zh) * 1990-11-10 1997-11-05 天津市计划生育研究所 新促***释放激素拮抗类似物的制备方法
IL101074A (en) * 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
DE593491T1 (de) * 1991-04-25 1994-11-17 Romano S.-Cergue Deghenghi LHRH-Antagonisten.
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
WO1993003752A1 (en) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide having dopamine stimulating activity
WO1993003751A1 (en) * 1991-08-26 1993-03-04 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
US5656727A (en) * 1992-09-15 1997-08-12 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US6566330B1 (en) * 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
EP0994718B1 (en) 1997-06-20 2005-08-17 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
EP1711159B1 (en) 2003-12-30 2013-03-20 Durect Corporation Solid implants containing a block copolymer for controlled release of a gnrh compound
JP5361210B2 (ja) * 2008-02-22 2013-12-04 キヤノン株式会社 樹脂組成物および成形体
CN102584945A (zh) * 2012-02-09 2012-07-18 深圳翰宇药业股份有限公司 一种醋酸加尼瑞克的制备方法
CN104231055A (zh) * 2013-06-18 2014-12-24 深圳翰宇药业股份有限公司 加尼瑞克前体以及由其制备醋酸加尼瑞克的方法
CN109443592A (zh) * 2018-09-19 2019-03-08 东华大学 一种温敏嵌段共聚物低临界溶解温度的测定方法
US20220267347A1 (en) 2019-07-29 2022-08-25 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
WO2023072284A1 (zh) 2021-11-01 2023-05-04 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215038A (en) * 1978-10-16 1980-07-29 The Salk Institute For Biological Studies Peptides which inhibit gonadal function
US4419347A (en) * 1980-10-06 1983-12-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4667014A (en) * 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
US4481190A (en) * 1982-12-21 1984-11-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
ZA846154B (en) * 1983-08-16 1985-03-27 Akzo Nv Lh-rh antagonists
EP0145032B1 (en) * 1983-08-16 1987-11-04 Akzo N.V. Lh- rh antagonists
US4569927A (en) * 1984-02-23 1986-02-11 The Salk Institute For Biological Studies GnRH Antagonists IV
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
EP0301850A3 (en) * 1987-07-31 1990-10-31 Syntex (U.S.A.) Inc. Lhrh antagonist analogs and 19-nor-progestational steroids for therapy
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
EP0683792B1 (en) * 1992-12-18 2001-09-26 Abbott Laboratories Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5516759A (en) * 1994-12-08 1996-05-14 Tap Holdings Inc. LHRH antagonists having lactam groups at the N-terminus
US5574011A (en) * 1995-04-04 1996-11-12 Tien; Henry C. Compositions and methods for the treatment of male-pattern baldness

Also Published As

Publication number Publication date
LU90657I2 (fr) 2001-01-15
ATE109159T1 (de) 1994-08-15
NO922632L (no) 1988-08-08
BR1100688A (pt) 2000-04-18
KR890013060A (ko) 1989-09-21
NZ223403A (en) 1990-10-26
ES2056908T3 (es) 1994-10-16
DE10075027I1 (de) 2000-11-30
NL300016I2 (nl) 2001-01-02
EP0277829A3 (en) 1990-10-31
HK35997A (en) 1997-03-27
HU215855B (hu) 2001-02-28
US5767082A (en) 1998-06-16
FI92211B (fi) 1994-06-30
ZA88795B (en) 1989-10-25
NO880494D0 (no) 1988-02-04
JPS63201199A (ja) 1988-08-19
HUT46340A (en) 1988-10-28
EP0277829B1 (en) 1994-07-27
FI880509A (fi) 1988-08-06
EP0277829A2 (en) 1988-08-10
DK57288A (da) 1988-08-06
HU210819A9 (en) 1995-08-28
NL300016I1 (nl) 2000-11-01
IE63707B1 (en) 1995-05-31
FI930694A0 (fi) 1993-02-17
AU614275B2 (en) 1991-08-29
IL85316A (en) 1992-07-15
AU1126588A (en) 1988-08-11
MX9202737A (es) 1992-06-30
IL85316A0 (en) 1988-07-31
KR930008095B1 (ko) 1993-08-25
NO2001001I1 (no) 2001-02-05
DE10075027I2 (de) 2004-07-01
DK173544B1 (da) 2001-02-19
DE3850789T2 (de) 1995-03-09
NO301014B1 (no) 1997-09-01
JPH0791314B2 (ja) 1995-10-04
FI92211C (fi) 1994-10-10
US4801577A (en) 1989-01-31
NO880494L (no) 1988-08-08
DK57288D0 (da) 1988-02-04
FI880509A0 (fi) 1988-02-04
DE3850789D1 (de) 1994-09-01
IE880298L (en) 1988-08-05
NO176440B (no) 1994-12-27
FI92326C (fi) 1994-10-25
FI92326B (fi) 1994-07-15
NO922632D0 (no) 1992-07-03
HUT63855A (en) 1993-10-28
CA1339043C (en) 1997-04-01
NO176440C (no) 1995-04-05

Similar Documents

Publication Publication Date Title
FI930694A (fi) Menetelmä terapeuttisesti käyttökelpoisten nonapeptidi- ja dekapeptidianalogien valmistamiseksi, jotka ovat LHRH:n antagonisteja
IE831359L (en) Lhrh antagonists
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
NO960549L (no) Fremgangsmåte for modulering av den humane seksualrespons
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
DE19975052I2 (de) LHRH Antagonisten, deren Herstellung und entsprechende pharmazeutische Zubereitungen.
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
NO167924C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive thymopentinanaloger
ES8800946A1 (es) Un procedimiento para preparar derivados de guanina
KR920004418A (ko) 브래디키닌 길항제
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
ES2133295T3 (es) Peptidos ciclicos y su uso.
DE69630583D1 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
ATE201693T1 (de) Hämoregulierende peptide
IS4392A (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
MX6834E (es) Procedimiento para preparar compuestos analogos de la prostaciclina
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
YU177991A (sh) Postupak konstruisanja i sinteze luteinizovanog hormona koji oslobadja hormonske antagone
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE211489T1 (de) Chitosan enthaltende zusammensetzung
ES2138668T3 (es) Nuevos derivados de peptidos terapeuticamente activos en la cadena de coagulacion sanguinea, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1263913B (it) Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
BB Publication of examined application
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L174

Extension date: 20130203